仙乐健康
(300791)
| 流通市值：43.06亿 | | | 总市值：51.60亿 |
| 流通股本：2.57亿 | | | 总股本：3.08亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 874,692,227.68 | 732,394,102.61 | 636,417,561.45 | 595,137,220.14 |
| 结算备付金 | - | - | - | 0 |
| 拆出资金 | - | - | - | 0 |
| 交易性金融资产 | 115,053,352.29 | 50,028,973.82 | 32,892,833.68 | 5,001,931.51 |
| 衍生金融资产 | 34,746 | 34,746 | 28,081.26 | 16,704.33 |
| 应收票据及应收账款 | 774,876,583.25 | 776,761,656.52 | 692,452,703.54 | 688,945,071.14 |
| 其中：应收票据 | 2,090,000 | 450,073.88 | 4,352,760.81 | 5,886,483.87 |
| 应收账款 | 772,786,583.25 | 776,311,582.64 | 688,099,942.73 | 683,058,587.27 |
| 应收款项融资 | 14,531,440.23 | 7,335,226.4 | 16,534,657.55 | 2,317,251.06 |
| 预付款项 | 86,059,057.34 | 20,570,233.83 | 12,551,449.08 | 16,732,225.16 |
| 应收保费 | - | - | - | 0 |
| 应收分保账款 | - | - | - | 0 |
| 应收分保合同准备金 | - | - | - | 0 |
| 其他应收款合计 | 15,367,745.41 | 27,023,444.69 | 6,613,651.19 | 11,578,155.18 |
| 其中:应收利息 | - | - | - | 0 |
| 应收股利 | - | - | - | 0 |
| 买入返售金融资产 | - | - | - | 0 |
| 存货 | 606,715,173.14 | 595,681,077.32 | 471,599,613.98 | 458,242,430.95 |
| 合同资产 | - | - | - | 0 |
| 一年内到期的非流动资产 | 984,531.7 | 54,648,849.75 | 97,559,124.25 | 98,197,759.16 |
| 其他流动资产 | 43,563,977.36 | 51,085,161.61 | 44,846,627.57 | 46,049,566.97 |
| 流动资产合计 | 2,531,878,834.4 | 2,315,563,472.55 | 2,011,496,303.55 | 1,922,218,315.6 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | - | - | 0 |
| 债权投资 | - | - | - | 0 |
| 其他债权投资 | - | - | - | 0 |
| 长期应收款 | - | - | - | 0 |
| 长期股权投资 | 132,136,429.71 | 137,224,072.6 | 140,297,411.13 | 143,343,964.41 |
| 其他权益工具投资 | - | - | - | 0 |
| 其他非流动金融资产 | - | - | 23,229,575.84 | 23,229,575.85 |
| 投资性房地产 | - | - | - | 0 |
| 固定资产 | 1,792,159,217.78 | 1,814,923,666.8 | 1,802,389,341.26 | 1,789,478,484.85 |
| 在建工程 | 163,608,468.35 | 164,570,461.53 | 216,142,846.46 | 168,846,730.96 |
| 生产性生物资产 | - | - | - | 0 |
| 油气资产 | - | - | - | 0 |
| 使用权资产 | 200,387,307.99 | 209,516,412.88 | 222,726,248.31 | 233,351,736.34 |
| 无形资产 | 443,444,810.1 | 437,168,669.38 | 442,802,897.91 | 459,885,472.76 |
| 开发支出 | 37,004,900.89 | 37,465,157.71 | 37,640,717.94 | 34,750,648.5 |
| 商誉 | 403,330,847.35 | 409,184,231.88 | 425,461,558.16 | 427,105,754.92 |
| 长期待摊费用 | 181,998,797.71 | 177,740,597.94 | 162,093,218.71 | 172,863,558.15 |
| 递延所得税资产 | 134,574,869.73 | 147,399,278.73 | 166,595,361.39 | 147,120,966.13 |
| 其他非流动资产 | 41,223,717.33 | 42,726,898.48 | 68,202,388.73 | 68,524,367.64 |
| 非流动资产合计 | 3,529,869,366.94 | 3,577,919,447.93 | 3,707,581,565.84 | 3,668,501,260.51 |
| 资产总计 | 6,061,748,201.34 | 5,893,482,920.48 | 5,719,077,869.39 | 5,590,719,576.11 |
| 流动负债: | | | | |
| 短期借款 | 310,263,328 | 340,450,774.72 | 183,769,843.37 | 118,681,035.69 |
| 向中央银行借款 | - | - | - | 0 |
| 吸收存款及同业存放 | - | - | - | 0 |
| 拆入资金 | - | - | - | 0 |
| 交易性金融负债 | - | - | - | 0 |
| 衍生金融负债 | 2,860,704.52 | 3,645,130.64 | 2,094,617.75 | 1,001,274.07 |
| 应付票据及应付账款 | 573,415,139.39 | 549,835,324.23 | 388,905,033.67 | 438,957,249.7 |
| 其中：应付票据 | 79,577,450.7 | 19,851,175.87 | - | 0 |
| 应付账款 | 493,837,688.69 | 529,984,148.36 | 388,905,033.67 | 438,957,249.7 |
| 预收款项 | - | - | - | 0 |
| 合同负债 | 45,534,812.52 | 43,598,575.15 | 44,511,667.58 | 43,318,522.79 |
| 卖出回购金融资产款 | - | - | - | 0 |
| 应付手续费及佣金 | - | - | - | 0 |
| 应付职工薪酬 | 80,776,158.29 | 67,299,134.76 | 76,377,900.6 | 94,986,539.54 |
| 应交税费 | 38,083,164.87 | 55,028,079.67 | 47,549,184.48 | 44,385,999.07 |
| 其他应付款合计 | 162,457,652.47 | 151,837,940.26 | 245,183,408.88 | 194,645,171.11 |
| 其中:应付利息 | 1,121,992.62 | 545,002.32 | - | 234,204.83 |
| 应付股利 | 1,613,449.52 | 1,944,177.59 | 2,457,314 | 2,457,314 |
| 应付分保账款 | - | - | - | 0 |
| 保险合同准备金 | - | - | - | 0 |
| 代理买卖证券款 | - | - | - | 0 |
| 代理承销证券款 | - | - | - | 0 |
| 一年内到期的非流动负债 | 1,175,397,524.93 | 1,167,022,381.47 | 100,509,741.97 | 120,394,363.06 |
| 其他流动负债 | 2,172,467.34 | 4,458,724.02 | 1,017,613.08 | 3,747,014.53 |
| 流动负债合计 | 2,390,960,952.33 | 2,383,176,064.92 | 1,089,919,011.38 | 1,060,117,169.56 |
| 非流动负债: | | | | |
| 长期借款 | 262,717,057.2 | 127,372,413.23 | 114,093,200.46 | 56,600,174.5 |
| 应付债券 | - | - | 1,098,498,549.45 | 1,080,507,076.66 |
| 优先股 | - | - | - | 0 |
| 永续债 | - | - | - | 0 |
| 租赁负债 | 214,820,247.05 | 213,170,172.17 | 312,793,585.65 | 307,410,448.55 |
| 长期应付款 | - | - | - | 0 |
| 长期应付职工薪酬 | - | - | - | 0 |
| 预计负债 | - | - | 2,138,291.2 | 1,762,873.85 |
| 递延收益 | 92,865,140.89 | 95,053,447.85 | 96,286,627.42 | 98,172,529.49 |
| 递延所得税负债 | 23,678,784.1 | 23,227,119.55 | 38,350,211.28 | 26,753,418.23 |
| 其他非流动负债 | - | - | - | 0 |
| 非流动负债合计 | 594,081,229.24 | 458,823,152.8 | 1,662,160,465.46 | 1,571,206,521.28 |
| 负债合计 | 2,985,042,181.57 | 2,841,999,217.72 | 2,752,079,476.84 | 2,631,323,690.84 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 308,064,042 | 308,225,672 | 307,644,663 | 307,634,663 |
| 其他权益工具 | 171,040,742.49 | 171,040,742.49 | 171,040,742.49 | 171,040,742.49 |
| 资本公积 | 915,047,376.39 | 918,873,829.05 | 913,807,562.82 | 905,919,679.9 |
| 减:库存股 | 64,855,866.95 | 71,690,367.88 | 69,344,282.47 | 69,222,182.47 |
| 其他综合收益 | -39,343,427.88 | 443,656.02 | -21,843,799.81 | 20,257,585.49 |
| 专项储备 | - | - | - | 0 |
| 盈余公积 | 126,346,342.5 | 126,346,342.5 | 126,346,342.5 | 126,346,342.5 |
| 一般风险准备 | - | - | - | 0 |
| 未分配利润 | 1,670,877,517.44 | 1,593,722,418.21 | 1,530,261,026.25 | 1,480,355,435.66 |
| 归属于母公司股东权益合计 | 3,087,176,725.99 | 3,046,962,292.39 | 2,957,912,254.78 | 2,942,332,266.57 |
| 少数股东权益 | -10,470,706.22 | 4,521,410.37 | 9,086,137.77 | 17,063,618.7 |
| 股东权益合计 | 3,076,706,019.77 | 3,051,483,702.76 | 2,966,998,392.55 | 2,959,395,885.27 |
| 负债和股东权益合计 | 6,061,748,201.34 | 5,893,482,920.48 | 5,719,077,869.39 | 5,590,719,576.11 |
| 公告日期 | 2026-10-24 | 2026-08-29 | 2026-04-24 | 2026-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |